Search - tctmd.com

Displaying 1 - 20 of 140

Sort: Relevancy | Date

Presentation TCT 2024

TCT 959: Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing Transcatheter Aortic Valve Replacement

Presenter: Marisa Avvedimento

October 30, 2024

Presentation TCT 2024

Mid-Term Outcomes of Mitral Valve in Valve Therapy in the United States

Presenter: Mackram Eleid

October 27, 2024

Presentation TCT 2024

M-TEER for Moderate to Severe FMR in Symptomatic Heart Failure: Comparison of RESHAPE-HF2 Trial Results With Outcomes in MITRA-FR and COAPT

Presenter: Stefan Anker

October 27, 2024

Presentation TCT 2024

TriClip Outcomes in Patients With CIED Leads Results From the TRILUMINATE Pivotal Trial

Presenter: Hursh naik

October 27, 2024

Presentation TCT 2024

TRILUMINATE Pivotal Trial: Outcomes in the Primary Analysis Population vs Subsequent Enrollment

Presenter: Gilbert Tang

October 27, 2024

Presentation TCT 2024

Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the EuroTR Registry

Presenter: Lukas Stolz

October 27, 2024

Presentation NY Valves 2024

Next Generation Decision Support With AI-Based Predictive Modeling for Improved Long Term Outcomes (DASI Simulations)

Presenter: Lakshmi Prasad Dasi

June 07, 2024

Presentation NY Valves 2024

Clinical Outcomes According to Aortic Stenosis Management: Insights From Real-World Practice

Presenter: Augustin Coisne

June 07, 2024

Presentation NY Valves 2024

In younger patients receiving TAVR: why does the first intervention matter?

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

Presenter: Rebecca T. Hahn

June 06, 2024

Presentation NY Valves 2024

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Presenter: David J. Cohen

June 06, 2024

Presentation NY Valves 2024

Which endpoints and definitions matter for assessment of bioprosthetic valve durability following TAVR?

Presenter: Philippe Pibarot

June 06, 2024

Presentation TCT 2023

TCT 1040: GeminiOne TEER Device & Early Clinical Experiences

Presenter: Saibal Kar

October 26, 2023

Presentation TCT 2023

TCT 766: Ethnicity and Aortic Stenosis: Presentation, Management and Outcomes

Presenter: Dhruva Biswas

October 26, 2023

Presentation TCT 2023

TCT 477: Safety and Efficacy of Mitral TEER in Patients with Low Ejection Fraction and Low Cardiac Index

Presenter: Agata Sularz

October 26, 2023

Presentation TCT 2023

TCT 720: Patient-Reported Outcomes in Tricuspid Valve Intervention: Patient Preference Results from the TRISCEND II Trial

Presenter: Colin Barker

October 26, 2023

Presentation TCT 2023

TCT 392: Prognostic impact of vasopressor test during edge-to-edge repair of secondary mitral regurgitation

Presenter: Jose Carlos Gonzalez Gutiérrez

October 26, 2023

Presentation TCT 2023

TCT 513: Real-world Clinical Outcomes and Health Care Utilization in Patients with Severe Tricuspid Regurgitation

Presenter: Mahesh Madhavan

October 26, 2023

Presentation TCT 2023

TCT 272: Impact of Post-procedural Systolic Dominant Pulmonary Venous Morphology on Outcomes after Transcatheter Edge-to-Edge Repair

Presenter: sahar samimi

October 26, 2023

Presentation TCT 2023

TCT 346: Impact of the Early COVID-19 Pandemic on Aortic Valve Replacement and Outcomes in France

Presenter: Graeme Prosperi-Porta

October 26, 2023

Advertisement

TCT 959: Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing Transcatheter Aortic Valve Replacement

Mid-Term Outcomes of Mitral Valve in Valve Therapy in the United States

M-TEER for Moderate to Severe FMR in Symptomatic Heart Failure: Comparison of RESHAPE-HF2 Trial Results With Outcomes in MITRA-FR and COAPT

TriClip Outcomes in Patients With CIED Leads Results From the TRILUMINATE Pivotal Trial

TRILUMINATE Pivotal Trial: Outcomes in the Primary Analysis Population vs Subsequent Enrollment

Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the EuroTR Registry

Next Generation Decision Support With AI-Based Predictive Modeling for Improved Long Term Outcomes (DASI Simulations)

Clinical Outcomes According to Aortic Stenosis Management: Insights From Real-World Practice

In younger patients receiving TAVR: why does the first intervention matter?

Mid-term outcomes of balloon expandable TAVR: do gradients and gender matter?

What would a patient consider a good outcome of intervention for symptomatic severe aortic stenosis

Which endpoints and definitions matter for assessment of bioprosthetic valve durability following TAVR?

TCT 1040: GeminiOne TEER Device & Early Clinical Experiences

TCT 766: Ethnicity and Aortic Stenosis: Presentation, Management and Outcomes

TCT 477: Safety and Efficacy of Mitral TEER in Patients with Low Ejection Fraction and Low Cardiac Index

TCT 720: Patient-Reported Outcomes in Tricuspid Valve Intervention: Patient Preference Results from the TRISCEND II Trial

TCT 392: Prognostic impact of vasopressor test during edge-to-edge repair of secondary mitral regurgitation

TCT 513: Real-world Clinical Outcomes and Health Care Utilization in Patients with Severe Tricuspid Regurgitation

TCT 272: Impact of Post-procedural Systolic Dominant Pulmonary Venous Morphology on Outcomes after Transcatheter Edge-to-Edge Repair

TCT 346: Impact of the Early COVID-19 Pandemic on Aortic Valve Replacement and Outcomes in France

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content